Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2004-8-27
pubmed:abstractText
This article discusses risk factors for cardiovascular disease in the minority community, including hypertension, obesity, diabetes,and diet. The minority community exhibits important population differences regarding risk and outcomes for cardiovascular disease. The complete explanation for these differential outcomes is lacking and likely to be multifactorial in origin; however, disparities in health care (differences in the quality of health care that are not due to access-related factors or clinical needs, to preferences, or to the appropriateness of the intervention) may emanate from decisions made by the patient, provider, or health care system. Hypertension as a disease entity is strikingly pathologic in African Americans. Correspondingly, the incidence of cardiovascular mortality due to hypertensive heart disease is fourfold higher in African Americans than in non-Hispanic whites. Hypertension and heart failure can be treated effectively in the minority community with a regimen of agents not dissimilar from that used for the general population. Treatment regimens should be individualized based on the disease presentation, associated comorbidity, and disease severity and not on something as arbitrary as race.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0025-7125
pubmed:author
pubmed:issnType
Print
pubmed:volume
88
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1347-68, xii-xiii
pubmed:dateRevised
2009-11-3
pubmed:meshHeading
pubmed-meshheading:15331320-Adrenergic beta-Antagonists, pubmed-meshheading:15331320-African Americans, pubmed-meshheading:15331320-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:15331320-Antihypertensive Agents, pubmed-meshheading:15331320-Cause of Death, pubmed-meshheading:15331320-Clinical Trials as Topic, pubmed-meshheading:15331320-Cost of Illness, pubmed-meshheading:15331320-Delivery of Health Care, pubmed-meshheading:15331320-Diuretics, pubmed-meshheading:15331320-Epidemiologic Studies, pubmed-meshheading:15331320-Health Services Accessibility, pubmed-meshheading:15331320-Heart Failure, pubmed-meshheading:15331320-Hispanic Americans, pubmed-meshheading:15331320-Humans, pubmed-meshheading:15331320-Hypertension, pubmed-meshheading:15331320-Incidence, pubmed-meshheading:15331320-Minority Groups, pubmed-meshheading:15331320-Obesity, pubmed-meshheading:15331320-Patient Selection, pubmed-meshheading:15331320-Practice Guidelines as Topic, pubmed-meshheading:15331320-Primary Prevention, pubmed-meshheading:15331320-Risk Factors, pubmed-meshheading:15331320-Treatment Outcome, pubmed-meshheading:15331320-United States, pubmed-meshheading:15331320-Vasodilator Agents
pubmed:year
2004
pubmed:articleTitle
The prevention of heart failure in minority communities and discrepancies in health care delivery systems.
pubmed:affiliation
The University of Texas Southwestern Medical Center, Dallas, TX 75390-9047, USA. clyde.yancy@utsouthwestern.edu
pubmed:publicationType
Journal Article, Review